Connecting specialties
It addresses regenerative medicine across clinical and basic medicine, cell and tissue engineering, materials science, bioethics, law, and health economics.
An academic society connecting research, clinical practice, cell processing, ethics, and legal systems in regenerative medicine. Its roles and certification are explained in plain words.
The society is a forum where specialists discuss research, education, and systems. Membership or certification helps you understand a physician's background.
Whether an individual treatment suits you, works, or is safe must still be judged separately through the disease, symptoms, test results, methods, evidence, and risks.
What the Japanese Society for Regenerative Medicine is — its purpose, the research fields it covers, and what it means for patients, from official materials.
How the society evolved from the 1978 cell therapy study group, and how its scope broadened over time.
How academic meetings, journals, and education programs let the society share research findings and train specialists.
Certification systems such as certified regenerative-medicine physicians and clinical cell cultivators — and why certification is not a treatment guarantee.
The Act on the Safety of Regenerative Medicine, cell-processing management, and provider plans, organized from a patient's viewpoint.
How to find JST- and AMED-linked public research information, and the difference between active research and available treatment.
The steps from cell collection, processing, and storage to administration — and why quality control in cell-processing facilities matters for safety.
How compensation works around private care and clinical research, and what to confirm before signing a treatment contract.
Who can join the society and what information is accessible — membership and learning entry points explained in plain language.
Final checkpoints for reading information without confusing society affiliation, physician review, and treatment evidence.
It addresses regenerative medicine across clinical and basic medicine, cell and tissue engineering, materials science, bioethics, law, and health economics.
It shares findings and knowledge through meetings, journals, newsletters, awards, and educational content.
It publishes expert information on cell quality and safety, cell processing, and the Act on the Safety of Regenerative Medicine.
It certifies physicians, dentists, cell culture technologists, and facility staff who support regenerative medicine.
The official history traces how regenerative medicine expanded from cell therapy into tissue engineering, dentistry, clinical practice, and regulation.
See the official historyThrough education programs and examinations in law, ethics, and cell processing, the society certifies multiple professions. Each credential means something different.
A system checking responsibility for explaining standard care, knowledge of culture methods and cell properties, indication judgment with specialists, ethical and legal knowledge, and sufficient experience.
Covers knowledge and practical ability in facility structure, manufacturing, quality control, and operational management.
Certification for technologists in cell culture and processing. It does not directly certify treatment effects for patients.
Certification describes qualification requirements. It never guarantees the effectiveness, safety, cost-effectiveness, or suitability of any specific treatment for you.
The “new law” pages carry specialist materials on cell processing, aseptic operation, cell storage, and provision-plan templates.
The official site notes the amended act took effect on May 31, 2025, and older wording may remain in materials. Always check document dates alongside current MHLW and PMDA information.
See the regulatory informationTarget disease, symptoms, and patient conditions
Positioning: research, approved care, clinical research, or private care
Studies and comparators supporting the expected benefit
Known risks, uncertainties, and post-treatment observation
Other options, watchful waiting, and second opinions
Total cost including collection, processing, administration, tests, and visits, plus contract terms
This site lists Yoshitomo Chihara as a medical reviewer. Membership in the Japanese Society for Regenerative Medicine is one affiliation in his profile. Society membership and per-article review scope, dates, and treatment evaluations are shown separately.